Service Corporation International (SCI) Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
Event summary combining transcript, slides, and related documents.
Raymond James & Associates’ 46th Annual Institutional Investors Conference 2025 summary
3 Feb, 2026Industry and company outlook
Earnings per share have grown 8%-12% annually over the past decade, driven by organic growth, new builds, and M&A activity.
COVID led to a temporary surge in funeral volumes, pulling forward demand; normalization is expected by 2025.
Demographic shifts, especially the aging Baby Boomer generation and increased Asian and Hispanic consumer presence, are expected to drive future growth.
The company benefits from a 60%-70% fixed cost structure, supporting incremental margin and profit growth as volumes rise.
M&A environment and strategy
Private equity is entering the industry but faces barriers due to the need for scale and existing synergies.
Strategic buyers have an advantage over financial buyers due to national scale and immediate synergies.
M&A spending reached $180 million last year, exceeding guidance due to increased opportunities post-COVID.
Larger, multi-location independents in major markets are now more likely to sell, often due to generational fatigue.
The company maintains discipline in acquisition pricing and focuses on long-term relationships with sellers.
Technology and sales force productivity
Pre-need sales rose from $1.8 billion pre-COVID to $2.8 billion post-COVID, with a smaller sales force enabled by technology.
Investments in CRM, point-of-sale, and virtual meeting technology have driven efficiency and sales growth.
Ongoing digital investments of $20-$25 million are planned to further enhance sales and operational efficiency.
Sales force turnover has been reduced by half over the past decade through technology and personnel investment.
Latest events from Service Corporation International
- Urban network, pre-need backlog, and tech-driven efficiency fuel growth and future outlook.SCI
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Adjusted EPS rose 8% in Q4 and 9% for the year, with 2026 guidance targeting further growth.SCI
Q4 202513 Feb 2026 - Normalized growth, margin expansion, and evolving cremation trends shape the outlook.SCI
BofA Securities Leveraged Finance Conference 20253 Feb 2026 - Q2 revenue up, adjusted EPS down; strong cash flow and capital returns; guidance at lower end.SCI
Q2 20242 Feb 2026 - Q3 2024 delivered stable profits, strong cash flow, and record acquisitions for future growth.SCI
Q3 202417 Jan 2026 - Stabilized volumes, moderated cremation shifts, and strong pre-need sales drive 2026 growth.SCI
UBS Global Healthcare Conference 202513 Jan 2026 - Strong market position, robust cash flow, and strategic growth drive superior shareholder returns.SCI
Investor presentation13 Jan 2026 - Strong market position, robust returns, and growth driven by scale and preneed strategy.SCI
Investor presentation13 Jan 2026 - Industry leader with strong cash flow, superior returns, and 2025 EPS growth aligned with targets.SCI
Investor presentation13 Jan 2026